Gene · 8451
Papers1,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer. | Cells | 2021 | 33920220 | PubTator, text mining | PubMed |
| Multiomic Analysis of Cereblon Expression and Its Prognostic Value in Kidney Renal Clear Cell Carcinoma, Lung Adenocarcinoma, and Skin Cutaneous Melanoma. | J Pers Med | 2021 | 33916291 | PubTator, text mining | PubMed |
| IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion. | Nat Commun | 2021 | 33911083 | PubTator, text mining | PubMed |
| Advances in Cancer Treatment by Targeting the Neddylation Pathway. | Front Cell Dev Biol | 2021 | 33898451 | PubTator, text mining | PubMed |
| OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. | Adv Sci (Weinh) | 2021 | 33898171 | PubTator, text mining | PubMed |
| Sp1 is a substrate of Keap1 and regulates the activity of CRL4AWDR23 ubiquitin ligase toward Nrf2. | J Biol Chem | 2021 | 33895141 | PubTator, text mining | PubMed |
| Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients. | Onco Targets Ther | 2021 | 33888994 | PubTator, text mining | PubMed |
| Integrative Analysis of DNA Methylation Data and Transcriptome Data Identified a DNA Methylation-Dysregulated Four-LncRNA Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma. | Front Cell Dev Biol | 2021 | 33869232 | PubTator, text mining | PubMed |
| Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. | Cell Biosci | 2021 | 33865438 | PubTator, text mining | PubMed |
| Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer. | Onco Targets Ther | 2021 | 33854336 | PubTator, text mining | PubMed |
| The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D. | Nature | 2021 | 33854239 | Swiss-Prot, curated | PubMed |
| CRL4AMBRA1 is a master regulator of D-type cyclins. | Nature | 2021 | 33854235 | PubTator, text mining | PubMed |
| AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity. | Nature | 2021 | 33854232 | Swiss-Prot, curated | PubMed |
| Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 33833131 | PubTator, text mining | PubMed |
| Targeting neddylation E2s: a novel therapeutic strategy in cancer. | J Hematol Oncol | 2021 | 33827629 | PubTator, text mining | PubMed |
| Cullin-RING Ubiquitin Ligase Regulatory Circuits: A Quarter Century Beyond the F-Box Hypothesis. | Annu Rev Biochem | 2021 | 33823649 | PubTator, text mining | PubMed |
| The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr. | Cell Host Microbe | 2021 | 33811831 | PubTator, text mining | PubMed |
| The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma. | Cancers (Basel) | 2021 | 33799793 | PubTator, text mining | PubMed |
| Structural Model for Recruitment of RIT1 to the LZTR1 E3 Ligase: Evidences from an Integrated Computational Approach. | J Chem Inf Model | 2021 | 33792302 | PubTator, text mining | PubMed |
| FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer. | Cell Death Dis | 2021 | 33767133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8451/papers?page=29